The September edition of Small Molecules of the Month, features a number of fascinating molecules and mechanisms, including a beta-lactamase inhibitor optimized to have single agent antibiotic activity, a biased agonist of S1P1 that minimizes receptor internalization in favor of GCPR agonism, an oral AR degrader similar to ARV-110 and a molecule that unfortunately demonstrates QTc prolongation in vivo without a significant in vitro signal.
Special thanks to reviewer Mike Koehler for commentary on the cover molecule, ETX0462, this month.
A slide deck with more details about each molecule is available.
Work smarter in two minutes. Join >4,000 drug hunters from every major biopharma company in the world getting drug discovery updates through our Drug Hunter e-mail newsletter. Unsubscribe anytime.
